These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16141522)
1. Inhibition of the nuclear factor-kappaB signaling pathway by leflunomide or triptolide also inhibits the anthralin-induced inflammatory response but does not affect keratinocyte growth inhibition. Feng H; Li XY; Zheng JR; Gao JW; Xu LF; Tang MY Biol Pharm Bull; 2005 Sep; 28(9):1597-602. PubMed ID: 16141522 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts. Lu Y; Fukuda K; Nakamura Y; Kimura K; Kumagai N; Nishida T Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2346-52. PubMed ID: 15980221 [TBL] [Abstract][Full Text] [Related]
3. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis. Manna SK; Mukhopadhyay A; Aggarwal BB J Immunol; 2000 Nov; 165(10):5962-9. PubMed ID: 11067959 [TBL] [Abstract][Full Text] [Related]
4. Triptolide alleviates hepatic ischemia/reperfusion injury by attenuating oxidative stress and inhibiting NF-κB activity in mice. Wu C; Wang P; Rao J; Wang Z; Zhang C; Lu L; Zhang F J Surg Res; 2011 Apr; 166(2):e205-13. PubMed ID: 21227469 [TBL] [Abstract][Full Text] [Related]
5. Triptolide suppresses IL-1beta-induced chemokine and stromelysin-1 gene expression in human colonic subepithelial myofibroblasts. Tao QS; Ren JA; Li JS Acta Pharmacol Sin; 2007 Jan; 28(1):81-8. PubMed ID: 17184586 [TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088 [TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory and Neuroprotective Effects of Triptolide via the NF-κB Signaling Pathway in a Rat MCAO Model. Bai S; Hu Z; Yang Y; Yin Y; Li W; Wu L; Fang M Anat Rec (Hoboken); 2016 Feb; 299(2):256-66. PubMed ID: 26575184 [TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes. Dai YQ; Jin DZ; Zhu XZ; Lei DL Neurosci Res; 2006 Jun; 55(2):154-60. PubMed ID: 16600409 [TBL] [Abstract][Full Text] [Related]
9. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex. Kizelsztein P; Komarnytsky S; Raskin I J Neuroimmunol; 2009 Dec; 217(1-2):28-37. PubMed ID: 19796825 [TBL] [Abstract][Full Text] [Related]
10. Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway. Song C; Wang Y; Cui L; Yan F; Shen S BMC Complement Altern Med; 2019 Aug; 19(1):198. PubMed ID: 31375092 [TBL] [Abstract][Full Text] [Related]
11. Effects of leflunomide on hyaluronan synthases (HAS): NF-kappa B-independent suppression of IL-1-induced HAS1 transcription by leflunomide. Stuhlmeier KM J Immunol; 2005 Jun; 174(11):7376-82. PubMed ID: 15905585 [TBL] [Abstract][Full Text] [Related]
12. Triptolide: a potent inhibitor of NF-kappa B in T-lymphocytes. Liu H; Liu ZH; Chen ZH; Yang JW; Li LS Acta Pharmacol Sin; 2000 Sep; 21(9):782-6. PubMed ID: 11501157 [TBL] [Abstract][Full Text] [Related]
13. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells. Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model. Wang X; Zhang L; Duan W; Liu B; Gong P; Ding Y; Wu X Mol Med Rep; 2014 Jul; 10(1):447-52. PubMed ID: 24789089 [TBL] [Abstract][Full Text] [Related]
15. Expression of NF-kappaB in epidermis and the relationship between NF-kappaB activation and inhibition of keratinocyte growth. Takao J; Yudate T; Das A; Shikano S; Bonkobara M; Ariizumi K; Cruz PD Br J Dermatol; 2003 Apr; 148(4):680-8. PubMed ID: 12752124 [TBL] [Abstract][Full Text] [Related]
16. The molecular mechanisms of the effect of Dexamethasone and Cyclosporin A on TLR4 /NF-κB signaling pathway activation in oral lichen planus. Ge Y; Xu Y; Sun W; Man Z; Zhu L; Xia X; Zhao L; Zhao Y; Wang X Gene; 2012 Oct; 508(2):157-64. PubMed ID: 22903029 [TBL] [Abstract][Full Text] [Related]
17. Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells. Zheng L; Jia J; Dai H; Wan L; Liu J; Hu L; Zhou M; Qiu M; Chen X; Chang L; Kim JY; Reckamp K; Raz DJ; Xia Z; Shen B Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533220 [TBL] [Abstract][Full Text] [Related]
18. Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-κB and MAP kinases in lipopolysaccharide-treated PC12 cells. Geng Y; Fang M; Wang J; Yu H; Hu Z; Yew DT; Chen W Phytother Res; 2012 Mar; 26(3):337-43. PubMed ID: 21717513 [TBL] [Abstract][Full Text] [Related]
19. Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B. Wang L; Zhang L; Hou Q; Zhu X; Chen Z; Liu Z Sci Rep; 2018 Jul; 8(1):10843. PubMed ID: 30022148 [TBL] [Abstract][Full Text] [Related]
20. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB. Imose M; Nagaki M; Kimura K; Takai S; Imao M; Naiki T; Osawa Y; Asano T; Hayashi H; Moriwaki H Hepatology; 2004 Nov; 40(5):1160-9. PubMed ID: 15455409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]